351 related articles for article (PubMed ID: 16484873)
1. Valvular heart disease is associated with nonfocal neuropsychiatric systemic lupus erythematosus.
Roldan CA; Gelgand EA; Qualls CR; Sibbitt WL
J Clin Rheumatol; 2006 Feb; 12(1):3-10. PubMed ID: 16484873
[TBL] [Abstract][Full Text] [Related]
2. Valvular heart disease by transthoracic echocardiography is associated with focal brain injury and central neuropsychiatric systemic lupus erythematosus.
Roldan CA; Gelgand EA; Qualls CR; Sibbitt WL
Cardiology; 2007; 108(4):331-7. PubMed ID: 17299260
[TBL] [Abstract][Full Text] [Related]
3. Correlation of magnetization transfer ratio histogram parameters with neuropsychiatric systemic lupus erythematosus criteria and proton magnetic resonance spectroscopy: association of magnetization transfer ratio peak height with neuronal and cognitive dysfunction.
Emmer BJ; Steup-Beekman GM; Steens SC; Huizinga TW; van Buchem MA; van der Grond J
Arthritis Rheum; 2008 May; 58(5):1451-7. PubMed ID: 18438847
[TBL] [Abstract][Full Text] [Related]
4. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus.
Sibbitt WL; Brandt JR; Johnson CR; Maldonado ME; Patel SR; Ford CC; Bankhurst AD; Brooks WM
J Rheumatol; 2002 Jul; 29(7):1536-42. PubMed ID: 12136916
[TBL] [Abstract][Full Text] [Related]
5. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
Kwieciński J; Kłak M; Trysberg E; Blennow K; Tarkowski A; Jin T
Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.
Sanna G; Bertolaccini ML; Cuadrado MJ; Laing H; Khamashta MA; Mathieu A; Hughes GR
J Rheumatol; 2003 May; 30(5):985-92. PubMed ID: 12734893
[TBL] [Abstract][Full Text] [Related]
7. Fluid Attenuated Inversion Recovery (FLAIR) imaging in neuropsychiatric systemic lupus erythematosus.
Sibbitt WL; Schmidt PJ; Hart BL; Brooks WM
J Rheumatol; 2003 Sep; 30(9):1983-9. PubMed ID: 12966602
[TBL] [Abstract][Full Text] [Related]
8. Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study.
Ainiala H; Dastidar P; Loukkola J; Lehtimäki T; Korpela M; Peltola J; Hietaharju A
Scand J Rheumatol; 2005; 34(5):376-82. PubMed ID: 16234185
[TBL] [Abstract][Full Text] [Related]
9. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST
Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328
[TBL] [Abstract][Full Text] [Related]
10. Evidence of central nervous system damage in patients with neuropsychiatric systemic lupus erythematosus, demonstrated by magnetization transfer imaging.
Bosma GP; Rood MJ; Zwinderman AH; Huizinga TW; van Buchem MA
Arthritis Rheum; 2000 Jan; 43(1):48-54. PubMed ID: 10643699
[TBL] [Abstract][Full Text] [Related]
11. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
[TBL] [Abstract][Full Text] [Related]
12. Antibodies in patients with neuropsychiatric systemic lupus erythematosus.
Kimura A; Kanoh Y; Sakurai T; Koumura A; Yamada M; Hayashi Y; Tanaka Y; Hozumi I; Takemura M; Seishima M; Inuzuka T
Neurology; 2010 Apr; 74(17):1372-9. PubMed ID: 20421581
[TBL] [Abstract][Full Text] [Related]
13. Diffusion tensor imaging in patients with acute onset of neuropsychiatric systemic lupus erythematosus: a prospective study of apparent diffusion coefficient, fractional anisotropy values, and eigenvalues in different regions of the brain.
Hughes M; Sundgren PC; Fan X; Foerster B; Nan B; Welsh RC; Williamson JA; Attwood J; Maly PV; Chenevert TL; McCune W; Gebarski S
Acta Radiol; 2007 Mar; 48(2):213-22. PubMed ID: 17354144
[TBL] [Abstract][Full Text] [Related]
14. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus.
Yoshio T; Hirata D; Onda K; Nara H; Minota S
J Rheumatol; 2005 Jan; 32(1):34-9. PubMed ID: 15630721
[TBL] [Abstract][Full Text] [Related]
15. Detection of cerebral involvement in patients with active neuropsychiatric systemic lupus erythematosus by the use of volumetric magnetization transfer imaging.
Bosma GP; Rood MJ; Huizinga TW; de Jong BA; Bollen EL; van Buchem MA
Arthritis Rheum; 2000 Nov; 43(11):2428-36. PubMed ID: 11083265
[TBL] [Abstract][Full Text] [Related]
16. Electroencephalography in the assessment of neuropsychiatric manifestations in antiphospholipid syndrome and systemic lupus erythematosus.
Lampropoulos CE; Koutroumanidis M; Reynolds PP; Manidakis I; Hughes GR; D'Cruz DP
Arthritis Rheum; 2005 Mar; 52(3):841-6. PubMed ID: 15751063
[TBL] [Abstract][Full Text] [Related]
17. Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings.
Tektonidou MG; Varsou N; Kotoulas G; Antoniou A; Moutsopoulos HM
Arch Intern Med; 2006 Nov; 166(20):2278-84. PubMed ID: 17101948
[TBL] [Abstract][Full Text] [Related]
18. Serum brain-derived neurotrophic factor levels as a novel biological marker for the activities of psychiatric symptoms in systemic lupus erythematosus.
Ikenouchi-Sugita A; Yoshimura R; Okamoto T; Umene-Nakano W; Ueda N; Hori H; Katsuki A; Saito K; Tanaka Y; Nakamura J
World J Biol Psychiatry; 2010 Mar; 11(2):121-8. PubMed ID: 20109107
[TBL] [Abstract][Full Text] [Related]
19. Libman-Sacks endocarditis and embolic cerebrovascular disease.
Roldan CA; Sibbitt WL; Qualls CR; Jung RE; Greene ER; Gasparovic CM; Hayek RA; Charlton GA; Crookston K
JACC Cardiovasc Imaging; 2013 Sep; 6(9):973-83. PubMed ID: 24029368
[TBL] [Abstract][Full Text] [Related]
20. Systemic lupus erythematosus with neuropsychiatric manifestation incurs high disease costs: a cost-of-illness study in Hong Kong.
Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
Rheumatology (Oxford); 2009 May; 48(5):564-8. PubMed ID: 19269959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
